Navigation Links
Child's Use of Certain Asthma Drugs Could Shorten Adult Height
Date:9/3/2012

MONDAY, Sept. 3 (HealthDay News) -- Young adults who used inhaled steroid drugs to treat their asthma when they were children are slightly shorter -- about half an inch -- than those who didn't use the drugs, a new study finds.

Researchers followed 943 children, ages 5 to 12, who were treated for mild to moderate asthma for more than four years. The children were divided into three groups. One group took the inhaled corticosteroid medication budesonide (brand names Pulmicort, Rhinocort) twice a day; the second group took the inhaled non-steroid medication nedocromil (brand name Tilade); and the third group took a placebo.

All the children took albuterol, a fast-acting drug for relief of acute asthma symptoms, and oral corticosteroids as needed to treat asthma symptoms.

The children were followed until they reached their full adult height -- age 18 or older for females and age 20 or older for males. The average height of patients who took budesonide was one-half inch shorter than those who took nedocromil or placebo. The slower growth occurred during the first two years of the study. As the study continued, the children who took budesonide remained one-half inch shorter than the other children until they reached their adult height.

"We found it made no difference if they were boys or girls or how long they had had asthma, or any other of these factors," study senior author Dr. Robert Strunk, a professor of pediatrics at Washington University School of Medicine in St. Louis, said in a university news release. "We also looked at the height of the parents, and that didn't have any impact, either."

The study was presented Sept. 3 at the European Respiratory Society meeting, in Vienna, and published online the same day in the New England Journal of Medicine.

Struck said asthma specialists at St. Louis Children's Hospital keep close tabs on the growth of patients who use inhaled steroids. The children are measured at every visit and doctors keep a growth curve.

"If a child is not growing as they should, we may reduce their steroid dose," Strunk explained. "But we think that the half-inch of lowered adult height must be balanced against the well-established benefit of inhaled corticosteroids in controlling persistent asthma. We will use the lowest effective dose to control symptoms to minimize concerns about effects on adult height."

Two other experts agreed that the slight decrease in height must be balanced against the benefits derived from the asthma medications.

"This is another example of the risks and benefits of a medical intervention," said Dr. Kenneth Bromberg, chair of pediatrics at the Brooklyn Hospital Center, in New York City. "It should be noted that inhaled steroids decrease the need for oral steroids, which would likely have more of an effect on both growth and other factors such as cataracts, glucose tolerance and immune function. The alternatives, in terms of life quality, are clearly in the direction of the [inhaled steroids] intervention."

Dr. Len Horovitz, a pulmonary specialist at Lenox Hill Hospital in New York City, echoed those sentiments.

"The loss of height compared to expected height was not dramatic in this study," he said, and "without inhaled steroids, some of these persistent, asthmatic children may well have suffered considerable morbidity [illness], which was prevented by the inhaled steroids."

Horovitz added that "all drugs are double-edged swords, and it was almost impossible to control significant childhood asthma before the advent of inhaled steroids in the 1990s."

More information

The American Academy of Allergy, Asthma and Immunology has more about childhood asthma.

-- Robert Preidt

SOURCES: Len Horovitz, M.D., pulmonary specialist, Lenox Hill Hospital, New York City; Kenneth Bromberg, M.D., chair of pediatrics, Brooklyn Hospital Center, New York City; Washington University School of Medicine in St. Louis, news release, Sept. 3, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Early use of stents better than medical therapy alone for certain patients
2. Blacks More Prone to Hypertension After Certain Strokes
3. Screening Debate Typifies Prostate Cancer Uncertainties
4. Certain Tick Bites Might Spur Red Meat Allergy
5. Neural precursor cells induce cell death in certain brain tumors
6. Certain Heart Meds May Give Chemo a Boost
7. Hepatitis C Virus Levels Higher in Certain Injection Drug Users
8. Abiraterone: Indication of considerable added benefit in certain patients
9. A high intake of certain dietary fats associated with lower live birth rates in IVF
10. Measuring the uncertainties of pandemic influenza
11. Certain Diets May Help Body Burn More Calories: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Child's Use of Certain Asthma Drugs Could Shorten Adult Height
(Date:3/24/2017)... ... March 24, 2017 , ... Digital Scientists, a software ... announce the opening of a Greenville, South Carolina location. The lab has ... in Greenville. , “We’ve been working with South Carolina clients for years from our ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... related services to families and business owners across eastern Michigan, is connecting with ... families struggling with financial difficulties. , The Oxford/Orion FISH Food Pantry works to ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... panels at the Advanced ERISA Benefit Claims Litigation seminar in Chicago, Illinois. ... Administrative Record, The majority of cases litigated under ERISA involve claims for long-term ...
(Date:3/24/2017)... ... 24, 2017 , ... Judy Buchanan, co-owner of Serenity Natural ... Judy says, “I am passionate about sharing Reiki as a holistic, complementary therapy ... challenging time.” , A Certified Medical Reiki™ Master trained by Raven Keys Medical ...
(Date:3/24/2017)... ... 2017 , ... “The Adventures of Joey, The Dog Who Barks at Puddles”: ... life to the fullest, as God intended. “The Adventures of Joey, The Dog Who ... grandmother pursuing her passion for writing, especially about truth and human behavior. , Published ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets has ... Development, Growth and Demand Forecast to 2022" report to their offering. ... The global wound care ... grow at a CAGR of 6.7% during 2016-2022 Among the ... the largest share in the global market in 2015. Among the various ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Dental Implants ... ... for Dental Implants in US$ Million. The report provides separate comprehensive analytics ... , Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2015 through 2022. ...
(Date:3/24/2017)... , March 24, 2017 ... providing high-quality and cost-effective drug development and ... pharmaceutical and biotechnology industry, announced today the ... ShangPharma will be consolidating the Contract ... (CMO) under Shanghai ChemPartner. These entities include ...
Breaking Medicine Technology: